The dialysis specialist Fresenius Medical Care (FMC) is changing its corporate structure. With success?
The dialysis specialist Fresenius Medical Care (FMC) is making progress with the restructuring of the group. In the second quarter, operating profit adjusted for special effects rose by eight percent to 433 million euros thanks to savings, as the MDAX-listed group in Bad Homburg announced. Sales fell slightly to 4.77 billion euros. Experts had expected revenue and earnings of this magnitude. The forecast for the current year was confirmed.
Since the end of November last year, the long-struggling company FMC and the DAX group Fresenius have gone their separate ways. Fresenius still holds a little more than 30 percent of FMC, but after the balance sheet separation, FMC’s contribution to the investment only appears in the financial results of the former parent company.
Source: Stern
